A group of compounds which can be described as benzo-pyrano-furano-benzenes which can be formed from ISOFLAVONES by internal coupling of the B ring to the 4-ketone position. Members include medicarpin, phaseolin, and pisatin which are found in FABACEAE.
Networked: 8 relevant articles (0 outcomes, 1 trials/studies) for this Bio-Agent, Comments

Bio-Agent Context: Research Results


1. Silveira, Edilberto R: 2 articles (09/2014 - 04/2006)
2. Pessoa, Cláudia: 2 articles (09/2014 - 04/2006)
3. Militão, Gardenia C G: 2 articles (09/2014 - 04/2006)
4. Lima, Mary Anne S: 2 articles (09/2014 - 04/2006)
5. Costa-Lotufo, Letícia V: 2 articles (09/2014 - 04/2006)
6. de Moraes, Manoel Odorico: 1 article (09/2014)
7. Veloso, Pérsio Alexandrino: 1 article (09/2014)
8. Prado, Marisa P: 1 article (09/2014)
9. Machado-Santelli, Gláucia M: 1 article (09/2014)
10. da Silva, Alcides J M: 1 article (02/2009)

Related Diseases

1. Leukemia
2. Neoplasms (Cancer)
09/01/2014 - "Pterocarpans induce tumor cell death through persistent mitotic arrest during prometaphase."
03/01/2005 - "Using cytotoxicity against KB cancer cells as a lead, bioguided-fractionation of the petroleum ether and ethyl acetate extracts of Bituminaria morisiana leaves led to the isolation of two new pterocarpans, namely 3,9-dihydroxy-4-(3,3-dimethylallyl) [6a R, 11a R]-pterocarpan, 3-hydroxy-4-(3,3-dimethylallyl)-4'',5''-dehydropyrano[8,9:2'',3''][6a R,11a R]-pterocarpan and one new isoflavone identified as 4',5''-dihydroxy-6''-methoxy-4'',4''-dimethyl-4'',5''-dihydro-6'' H-pyrano[2'',3'':7,8]-isoflavone. "
12/01/2003 - "By in situ staining with diphenylboric acid 2-aminoethyl ester, by thin-layer chromatography, reverse-phase high-performance liquid chromatography, and two-photon laser-scanning microscopy spectrometry, tumor-specific flavones, isoflavones and pterocarpans were detected, namely 7,4'-dihydroxyflavone (DHF), formononetin, and medicarpin. "
05/15/2008 - "Several classes of flavonoids [flavanoids (1-10), flavonol (11), isoflavones (12-18), isoflavanones (19-22), isoflavans (23-26), chalcones (27-30), auronol (31), pterocarpans (32-37), 2-arylbenzofuran (38), and neoflavonoid (39)] and lignans (40-42) isolated from the MeOH extract of Brazilian red propolis were investigated for their cytotoxic activity against a panel of six different cancer cell lines including murine colon 26-L5 carcinoma, murine B16-BL6 melanoma, murine Lewis lung carcinoma, human lung A549 adenocarcinoma, human cervix HeLa adenocarcinoma, and human HT-1080 fibrosarcoma cell lines. "
Order ALL the reference details at left...
3. Adenocarcinoma
4. Lewis Lung Carcinoma
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. DNA (Deoxyribonucleic Acid)
2. Isoflavones
3. Flavones
4. Chalcones
5. Lignans
6. Propolis (Bee Bread)
7. Flavonoids
8. neorautenol
9. erybraedin C
10. bitucarpin A

Related Therapies and Procedures

1. Lasers (Laser)

blog comments powered by Disqus
for Leukemia,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 2207 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>